103 related articles for article (PubMed ID: 6891601)
21. Reaction of nucleic acids with cis-diamminedichloroplatinum(II): interstrand cross-links.
Rahmouni A; Leng M
Biochemistry; 1987 Nov; 26(23):7229-34. PubMed ID: 3427071
[TBL] [Abstract][Full Text] [Related]
22. Studies of the binding interactions of cis-diamminedichloroplatinum(II) with amines and nucleosides by nitrogen-15 nuclear magnetic resonance.
Nee M; Roberts JD
Biochemistry; 1982 Sep; 21(20):4920-6. PubMed ID: 6890382
[TBL] [Abstract][Full Text] [Related]
23. Effect of the antitumor drug cis-diamminedichloroplatinum(II) and related platinum complexes on eukaryotic DNA replication.
Heiger-Bernays WJ; Essigmann JM; Lippard SJ
Biochemistry; 1990 Sep; 29(36):8461-6. PubMed ID: 2174701
[TBL] [Abstract][Full Text] [Related]
24. Isolation of the products resulting from the reaction of cis and trans diaminedichloroplatinum [II] with DNA and chromatin on the Dowex 50 W column.
Oliński R; Walter Z
Z Naturforsch C Biosci; 1984; 39(11-12):1057-62. PubMed ID: 6543411
[TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II).
Sundquist WI; Lippard SJ; Stollar BD
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8225-9. PubMed ID: 2446320
[TBL] [Abstract][Full Text] [Related]
26. Adducts of the antitumor drug cis-diamminedichloroplatinum(II) with DNA: formation, identification, and quantitation.
Fichtinger-Schepman AM; van der Veer JL; den Hartog JH; Lohman PH; Reedijk J
Biochemistry; 1985 Jan; 24(3):707-13. PubMed ID: 4039603
[TBL] [Abstract][Full Text] [Related]
27. Cytotoxicity and cellular accumulation of a new cis-diammineplatinum (II) complex containing procaine in murine L1210 cells sensitive and resistant to cis-diamminedichloroplatinum (II).
Viale M; Cafaggi S; Parodi B; Esposito M
Cancer Chemother Pharmacol; 1995; 35(5):371-6. PubMed ID: 7850917
[TBL] [Abstract][Full Text] [Related]
28. Trans-diammineplatinum(II): what makes it different from cis-DDP? Coordination chemistry of a neglected relative of cisplatin and its interaction with nucleic acids.
Lippert B
Met Ions Biol Syst; 1996; 33():105-41. PubMed ID: 8742842
[TBL] [Abstract][Full Text] [Related]
29. Formation of cis-diamminedichloroplatinum(II) 1,2-intrastrand cross-links on DNA is flanking-sequence independent.
Burstyn JN; Heiger-Bernays WJ; Cohen SM; Lippard SJ
Nucleic Acids Res; 2000 Nov; 28(21):4237-43. PubMed ID: 11058123
[TBL] [Abstract][Full Text] [Related]
30. Characterization of acquired resistance to cis-diamminedichloroplatinum (II) in BE human colon carcinoma cells.
Fram RJ; Woda BA; Wilson JM; Robichaud N
Cancer Res; 1990 Jan; 50(1):72-7. PubMed ID: 2293559
[TBL] [Abstract][Full Text] [Related]
31. Correlation between cell killing by cis-diamminedichloroplatinum(II) in six mammalian cell lines and binding of a cis-diamminedichloroplatinum(II)-DNA antiserum.
Terheggen PM; Emondt JY; Floot BG; Dijkman R; Schrier PI; den Engelse L; Begg AC
Cancer Res; 1990 Jun; 50(12):3556-61. PubMed ID: 2340504
[TBL] [Abstract][Full Text] [Related]
32. Mass spectrometry of cis-diamminedichloroplatinum(II) adducts with the dinucleosidemonophosphates d(ApG), d(GpG) and d(TpC) in an ion trap.
Hagemeister T; Linscheid M
J Mass Spectrom; 2002 Jul; 37(7):731-47. PubMed ID: 12125006
[TBL] [Abstract][Full Text] [Related]
33. Interaction of histone H1 with cis-platinum modified DNA.
Paneva EG; Spassovska NC; Grancharov KC; Zlatanova JS; Yaneva JN
Z Naturforsch C J Biosci; 1998; 53(1-2):135-8. PubMed ID: 9528130
[TBL] [Abstract][Full Text] [Related]
34. Isolation of the adducts of platinum complexes and nucleic acid bases on the Dowex 50 W column.
Oliński R; Walter Z
Z Naturforsch C Biosci; 1984; 39(11-12):1052-6. PubMed ID: 6543410
[TBL] [Abstract][Full Text] [Related]
35. Iododeoxyuridine chemosensitization of cis-diamminedichloroplatinum(II) in human bladder cancer cells.
Chi KH; Kunugi KA; Kinsella TJ
Cancer Res; 1994 May; 54(10):2701-6. PubMed ID: 8168100
[TBL] [Abstract][Full Text] [Related]
36. The influence of cysteine on the reaction of d-guanosine with cis-diamminedichloroplatinum (II).
Kulamowicz I; Oliński R; Walter Z
Z Naturforsch C Biosci; 1984; 39(1-2):180-2. PubMed ID: 6539035
[TBL] [Abstract][Full Text] [Related]
37. Differential uptake of cis-diamminedichloroplatinum (II) by sensitive and resistant murine L1210 leukemia cells.
Waud WR
Cancer Res; 1987 Dec; 47(24 Pt 1):6549-55. PubMed ID: 3677093
[TBL] [Abstract][Full Text] [Related]
38. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
Schmidt W; Chaney SG
Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
[TBL] [Abstract][Full Text] [Related]
39. Formation of a DNA monofunctional cis-platinum adduct cross-linking the intercalating drug N-methyl-2,7-diazapyrenium.
Malinge JM; Sip M; Blacker AJ; Lehn JM; Leng M
Nucleic Acids Res; 1990 Jul; 18(13):3887-91. PubMed ID: 2374713
[TBL] [Abstract][Full Text] [Related]
40. Polyclonal antibodies to quantitate cis-diamminedichloroplatinum(II)--DNA adducts in cancer patients and animal models.
Poirier MC; Reed E; Zwelling LA; Ozols RF; Litterst CL; Yuspa SH
Environ Health Perspect; 1985 Oct; 62():89-94. PubMed ID: 4085451
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]